US study says pumps increase quality of life for diabetics
This article was originally published in Clinica
Executive Summary
Implantable insulin pumps cut hypoglycaemic events and improve quality of life for diabetic patients who would otherwise inject their insulin, says a group of US researchers from the Johns Hopkins University in Baltimore. The findings come from the first large-scale, prospective, randomised trial of insulin pumps in type-II diabetics. The study also showed that patients with pumps avoided weight gain and had less day-to-day variability in their blood sugar.